©The Author(s) 2023.
World J Clin Oncol. Dec 24, 2023; 14(12): 570-583
Published online Dec 24, 2023. doi: 10.5306/wjco.v14.i12.570
Published online Dec 24, 2023. doi: 10.5306/wjco.v14.i12.570
Table 1 Used diagnostic tools for anaplastic thyroid carcinoma
| n | Modality |
| 1 | Plain ultrasound or preferably high resolution ultrasound |
| 2 | Core needle biopsy under ultrasound guidance preferably |
| 3 | FNA cytology under ultrasound guidance |
| 4 | Staging imaging (CT, MRI-MRA, 18F-FDG PET-CT) |
| 5 | Bronchoscopy |
| 6 | Esophagoscopy |
| 8 | Fiberoptic laryngoscopy |
| 9 | Molecular testing (BRAF, MEK, NTRK, RET, RAS, p53 genes) |
| 10 | MicroRNAs |
| 11 | PD-L1 expression |
| 12 | Liquid biopsy |
| 13 | Histopathology |
| 14 | Pathological TNM staging |
- Citation: Pavlidis ET, Galanis IN, Pavlidis TE. Update on current diagnosis and management of anaplastic thyroid carcinoma. World J Clin Oncol 2023; 14(12): 570-583
- URL: https://www.wjgnet.com/2218-4333/full/v14/i12/570.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i12.570